Detail Information of Epigenetic Regulations

General Information of Drug Transporter (DT)
DT ID	DTD0122 Transporter Info
Gene Name	SLC17A9
Transporter Name	Solute carrier family 17 member 9
Gene ID	63910
UniProt ID	Q9BYT1

Epigenetic Regulations of This DT (EGR)
Methylation
Pancretic ductal adenocarcinoma	11 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC17A9 in pancretic ductal adenocarcinoma			[ 1 ]
Location	5'UTR (cg13766864)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.17E+00	Statistic Test	p-value:2.66E-05; Z-score:1.29E+00
Methylation in Case	7.23E-01 (Median)	Methylation in Control	6.19E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC17A9 in pancretic ductal adenocarcinoma			[ 1 ]
Location	5'UTR (cg20366258)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.32E+00	Statistic Test	p-value:1.86E-04; Z-score:-9.13E-01
Methylation in Case	1.47E-01 (Median)	Methylation in Control	1.94E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC17A9 in pancretic ductal adenocarcinoma			[ 1 ]
Location	TSS1500 (cg18219563)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.13E+00	Statistic Test	p-value:3.65E-09; Z-score:5.82E-01
Methylation in Case	1.00E-01 (Median)	Methylation in Control	8.83E-02 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC17A9 in pancretic ductal adenocarcinoma			[ 1 ]
Location	TSS1500 (cg21951425)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:4.26E+00	Statistic Test	p-value:1.61E-06; Z-score:1.58E+00
Methylation in Case	1.81E-01 (Median)	Methylation in Control	4.24E-02 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC17A9 in pancretic ductal adenocarcinoma			[ 1 ]
Location	TSS1500 (cg25190638)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.03E+00	Statistic Test	p-value:4.36E-03; Z-score:6.14E-01
Methylation in Case	8.49E-01 (Median)	Methylation in Control	8.27E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC17A9 in pancretic ductal adenocarcinoma			[ 1 ]
Location	1stExon (cg20834681)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.34E+00	Statistic Test	p-value:5.99E-11; Z-score:2.25E+00
Methylation in Case	6.43E-01 (Median)	Methylation in Control	4.78E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC17A9 in pancretic ductal adenocarcinoma			[ 1 ]
Location	1stExon (cg06723421)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.02E+00	Statistic Test	p-value:2.77E-04; Z-score:7.09E-01
Methylation in Case	7.91E-01 (Median)	Methylation in Control	7.75E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC17A9 in pancretic ductal adenocarcinoma			[ 1 ]
Location	Body (cg16867817)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.09E+00	Statistic Test	p-value:6.88E-12; Z-score:-1.36E+00
Methylation in Case	6.28E-01 (Median)	Methylation in Control	6.87E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of SLC17A9 in pancretic ductal adenocarcinoma			[ 1 ]
Location	Body (cg23750338)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:3.95E-05; Z-score:-9.93E-01
Methylation in Case	8.12E-01 (Median)	Methylation in Control	8.34E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of SLC17A9 in pancretic ductal adenocarcinoma			[ 1 ]
Location	Body (cg14381448)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.09E+00	Statistic Test	p-value:1.44E-03; Z-score:-7.71E-01
Methylation in Case	5.44E-01 (Median)	Methylation in Control	5.91E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon11	Methylation of SLC17A9 in pancretic ductal adenocarcinoma			[ 1 ]
Location	Body (cg24585559)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.00E+00	Statistic Test	p-value:8.86E-03; Z-score:4.30E-02
Methylation in Case	8.46E-01 (Median)	Methylation in Control	8.45E-01 (Median)
Studied Phenotype	Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]
Experimental Material	Patient tissue samples
Prostate cancer	8 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC17A9 in prostate cancer			[ 2 ]
Location	5'UTR (cg00797102)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.19E+00	Statistic Test	p-value:3.97E-02; Z-score:1.17E+00
Methylation in Case	8.33E-01 (Median)	Methylation in Control	7.02E-01 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC17A9 in prostate cancer			[ 2 ]
Location	TSS1500 (cg25365006)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.11E+00	Statistic Test	p-value:3.35E-02; Z-score:1.69E+00
Methylation in Case	9.13E-01 (Median)	Methylation in Control	8.25E-01 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC17A9 in prostate cancer			[ 2 ]
Location	TSS200 (cg07719512)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.17E+00	Statistic Test	p-value:4.93E-02; Z-score:2.76E+00
Methylation in Case	7.75E-01 (Median)	Methylation in Control	6.61E-01 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC17A9 in prostate cancer			[ 2 ]
Location	Body (cg13681701)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.56E+00	Statistic Test	p-value:2.39E-02; Z-score:-2.61E+00
Methylation in Case	1.77E-01 (Median)	Methylation in Control	2.75E-01 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC17A9 in prostate cancer			[ 2 ]
Location	Body (cg08726801)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.51E+00	Statistic Test	p-value:2.82E-02; Z-score:2.17E+00
Methylation in Case	5.05E-01 (Median)	Methylation in Control	3.35E-01 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC17A9 in prostate cancer			[ 2 ]
Location	Body (cg10091752)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.54E+00	Statistic Test	p-value:3.12E-02; Z-score:-7.24E+00
Methylation in Case	2.77E-01 (Median)	Methylation in Control	4.26E-01 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC17A9 in prostate cancer			[ 2 ]
Location	Body (cg09958402)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.07E+00	Statistic Test	p-value:3.57E-02; Z-score:4.17E+00
Methylation in Case	9.31E-01 (Median)	Methylation in Control	8.72E-01 (Median)
Studied Phenotype	Prostate cancer[ ICD-11:2C82]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Significant hypermethylation of SLC17A9 in prostate cancer than that in healthy individual
Studied Phenotype	Prostate cancer [ICD-11:2C82]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:2.47E-07; Fold-change:0.322979631; Z-score:4.100890028
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Bladder cancer	14 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	TSS1500 (cg22883889)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.53E+00	Statistic Test	p-value:2.78E-08; Z-score:-6.28E+00
Methylation in Case	2.66E-01 (Median)	Methylation in Control	4.08E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	TSS1500 (cg21455983)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.27E+00	Statistic Test	p-value:1.79E-07; Z-score:-1.57E+01
Methylation in Case	6.50E-01 (Median)	Methylation in Control	8.27E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	TSS1500 (cg00727912)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.36E+00	Statistic Test	p-value:8.04E-05; Z-score:-3.01E+00
Methylation in Case	1.92E-01 (Median)	Methylation in Control	2.62E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	TSS200 (cg05534403)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.30E+00	Statistic Test	p-value:1.16E-02; Z-score:-1.69E+00
Methylation in Case	1.13E-01 (Median)	Methylation in Control	1.46E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	Body (cg07560932)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.61E+00	Statistic Test	p-value:2.55E-11; Z-score:-1.69E+01
Methylation in Case	5.41E-01 (Median)	Methylation in Control	8.70E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	Body (cg13044838)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.41E+00	Statistic Test	p-value:1.99E-08; Z-score:-1.50E+01
Methylation in Case	6.19E-01 (Median)	Methylation in Control	8.74E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	Body (cg12099423)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.88E+00	Statistic Test	p-value:3.94E-07; Z-score:-9.33E+00
Methylation in Case	3.49E-01 (Median)	Methylation in Control	6.55E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	Body (cg21627218)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.35E+00	Statistic Test	p-value:4.22E-07; Z-score:-4.31E+01
Methylation in Case	6.80E-01 (Median)	Methylation in Control	9.21E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	Body (cg24866407)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.74E+00	Statistic Test	p-value:1.11E-05; Z-score:-5.09E+00
Methylation in Case	3.99E-01 (Median)	Methylation in Control	6.95E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	Body (cg19142181)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.25E+00	Statistic Test	p-value:2.81E-04; Z-score:-3.84E+00
Methylation in Case	5.69E-01 (Median)	Methylation in Control	7.09E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon11	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	Body (cg00688402)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.16E+00	Statistic Test	p-value:4.29E-04; Z-score:-3.04E+00
Methylation in Case	5.41E-01 (Median)	Methylation in Control	6.26E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon12	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	Body (cg26733301)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:2.21E+00	Statistic Test	p-value:6.57E-04; Z-score:1.19E+01
Methylation in Case	2.29E-01 (Median)	Methylation in Control	1.04E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon13	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	Body (cg17221813)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:2.80E-02; Z-score:-6.30E-01
Methylation in Case	7.33E-01 (Median)	Methylation in Control	7.53E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon14	Methylation of SLC17A9 in bladder cancer			[ 3 ]
Location	3'UTR (cg13516768)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.54E+00	Statistic Test	p-value:1.11E-07; Z-score:-8.39E+00
Methylation in Case	5.68E-01 (Median)	Methylation in Control	8.71E-01 (Median)
Studied Phenotype	Bladder cancer[ ICD-11:2C94]
Experimental Material	Patient tissue samples
Breast cancer	18 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	TSS1500 (cg21455983)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.05E+00	Statistic Test	p-value:1.93E-03; Z-score:-8.63E-01
Methylation in Case	8.01E-01 (Median)	Methylation in Control	8.38E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	TSS1500 (cg00727912)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.08E+00	Statistic Test	p-value:1.53E-02; Z-score:5.24E-01
Methylation in Case	3.73E-01 (Median)	Methylation in Control	3.46E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	TSS200 (cg07173972)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:2.43E+00	Statistic Test	p-value:5.88E-10; Z-score:2.57E+00
Methylation in Case	2.47E-01 (Median)	Methylation in Control	1.02E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	TSS200 (cg26329715)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:2.08E+00	Statistic Test	p-value:1.55E-09; Z-score:1.74E+00
Methylation in Case	1.65E-01 (Median)	Methylation in Control	7.91E-02 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	TSS200 (cg00199007)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:2.02E+00	Statistic Test	p-value:3.80E-09; Z-score:2.24E+00
Methylation in Case	3.54E-01 (Median)	Methylation in Control	1.76E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	TSS200 (cg16552454)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.96E+00	Statistic Test	p-value:8.99E-09; Z-score:2.08E+00
Methylation in Case	3.14E-01 (Median)	Methylation in Control	1.60E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	TSS200 (cg05534403)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.27E+00	Statistic Test	p-value:3.54E-06; Z-score:1.23E+00
Methylation in Case	1.84E-01 (Median)	Methylation in Control	1.45E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	Body (cg26733301)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.88E+00	Statistic Test	p-value:1.41E-10; Z-score:2.30E+00
Methylation in Case	5.17E-01 (Median)	Methylation in Control	2.75E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	Body (cg13044838)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.08E+00	Statistic Test	p-value:2.42E-09; Z-score:-2.01E+00
Methylation in Case	8.14E-01 (Median)	Methylation in Control	8.76E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	Body (cg24866407)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.17E+00	Statistic Test	p-value:4.87E-08; Z-score:1.75E+00
Methylation in Case	7.42E-01 (Median)	Methylation in Control	6.34E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon11	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	Body (cg07560932)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.11E+00	Statistic Test	p-value:2.44E-06; Z-score:-1.54E+00
Methylation in Case	7.83E-01 (Median)	Methylation in Control	8.73E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon12	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	Body (cg15677087)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.16E+00	Statistic Test	p-value:1.21E-05; Z-score:-1.16E+00
Methylation in Case	7.09E-01 (Median)	Methylation in Control	8.23E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon13	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	Body (cg00688402)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.09E+00	Statistic Test	p-value:6.48E-04; Z-score:-1.20E+00
Methylation in Case	6.03E-01 (Median)	Methylation in Control	6.56E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon14	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	Body (cg12099423)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.18E+00	Statistic Test	p-value:7.65E-04; Z-score:-1.41E+00
Methylation in Case	5.63E-01 (Median)	Methylation in Control	6.64E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon15	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	Body (cg19142181)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.08E+00	Statistic Test	p-value:2.46E-03; Z-score:-9.02E-01
Methylation in Case	6.87E-01 (Median)	Methylation in Control	7.42E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon16	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	Body (cg21627218)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.02E+00	Statistic Test	p-value:7.56E-03; Z-score:-5.75E-01
Methylation in Case	9.03E-01 (Median)	Methylation in Control	9.17E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon17	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	Body (cg17221813)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.10E+00	Statistic Test	p-value:2.49E-02; Z-score:-5.27E-01
Methylation in Case	6.90E-01 (Median)	Methylation in Control	7.60E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon18	Methylation of SLC17A9 in breast cancer			[ 4 ]
Location	3'UTR (cg13516768)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.08E+00	Statistic Test	p-value:1.55E-04; Z-score:-1.05E+00
Methylation in Case	8.02E-01 (Median)	Methylation in Control	8.64E-01 (Median)
Studied Phenotype	Breast cancer[ ICD-11:2C60-2C6Z]
Experimental Material	Patient tissue samples
Renal cell carcinoma	8 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC17A9 in clear cell renal cell carcinoma			[ 5 ]
Location	TSS1500 (cg22883889)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.21E+00	Statistic Test	p-value:3.60E-06; Z-score:-2.75E+00
Methylation in Case	5.09E-01 (Median)	Methylation in Control	6.14E-01 (Median)
Studied Phenotype	Renal cell carcinoma[ ICD-11:2C90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC17A9 in clear cell renal cell carcinoma			[ 5 ]
Location	TSS1500 (cg00727912)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.15E+00	Statistic Test	p-value:5.54E-03; Z-score:-1.48E+00
Methylation in Case	3.43E-01 (Median)	Methylation in Control	3.94E-01 (Median)
Studied Phenotype	Renal cell carcinoma[ ICD-11:2C90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC17A9 in clear cell renal cell carcinoma			[ 5 ]
Location	TSS200 (cg16552454)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:2.57E+00	Statistic Test	p-value:3.62E-06; Z-score:1.70E+00
Methylation in Case	1.35E-01 (Median)	Methylation in Control	5.28E-02 (Median)
Studied Phenotype	Renal cell carcinoma[ ICD-11:2C90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC17A9 in clear cell renal cell carcinoma			[ 5 ]
Location	TSS200 (cg00199007)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.85E+00	Statistic Test	p-value:2.06E-05; Z-score:1.23E+00
Methylation in Case	1.31E-01 (Median)	Methylation in Control	7.11E-02 (Median)
Studied Phenotype	Renal cell carcinoma[ ICD-11:2C90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC17A9 in clear cell renal cell carcinoma			[ 5 ]
Location	TSS200 (cg26329715)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.53E+00	Statistic Test	p-value:1.94E-04; Z-score:1.13E+00
Methylation in Case	7.35E-02 (Median)	Methylation in Control	4.82E-02 (Median)
Studied Phenotype	Renal cell carcinoma[ ICD-11:2C90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC17A9 in clear cell renal cell carcinoma			[ 5 ]
Location	Body (cg17221813)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.07E+00	Statistic Test	p-value:4.94E-06; Z-score:-1.47E+00
Methylation in Case	8.20E-01 (Median)	Methylation in Control	8.80E-01 (Median)
Studied Phenotype	Renal cell carcinoma[ ICD-11:2C90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC17A9 in clear cell renal cell carcinoma			[ 5 ]
Location	Body (cg12099423)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.06E+00	Statistic Test	p-value:1.55E-04; Z-score:-9.21E-01
Methylation in Case	7.36E-01 (Median)	Methylation in Control	7.79E-01 (Median)
Studied Phenotype	Renal cell carcinoma[ ICD-11:2C90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC17A9 in clear cell renal cell carcinoma			[ 5 ]
Location	Body (cg26733301)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.31E+00	Statistic Test	p-value:1.60E-03; Z-score:1.07E+00
Methylation in Case	2.20E-01 (Median)	Methylation in Control	1.67E-01 (Median)
Studied Phenotype	Renal cell carcinoma[ ICD-11:2C90]
Experimental Material	Patient tissue samples
Colon cancer	8 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC17A9 in colon adenocarcinoma			[ 6 ]
Location	TSS1500 (cg05581394)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.28E+00	Statistic Test	p-value:3.37E-06; Z-score:-5.59E+00
Methylation in Case	6.24E-01 (Median)	Methylation in Control	7.97E-01 (Median)
Studied Phenotype	Colon cancer[ ICD-11:2B90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC17A9 in colon adenocarcinoma			[ 6 ]
Location	TSS200 (cg22113930)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.40E+00	Statistic Test	p-value:4.06E-06; Z-score:1.27E+00
Methylation in Case	6.48E-01 (Median)	Methylation in Control	4.64E-01 (Median)
Studied Phenotype	Colon cancer[ ICD-11:2B90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC17A9 in colon adenocarcinoma			[ 6 ]
Location	1stExon (cg12052661)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.16E+00	Statistic Test	p-value:1.21E-05; Z-score:1.95E+00
Methylation in Case	6.26E-01 (Median)	Methylation in Control	5.38E-01 (Median)
Studied Phenotype	Colon cancer[ ICD-11:2B90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC17A9 in colon adenocarcinoma			[ 6 ]
Location	Body (cg24712501)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.27E+00	Statistic Test	p-value:3.38E-06; Z-score:-2.08E+00
Methylation in Case	3.98E-01 (Median)	Methylation in Control	5.05E-01 (Median)
Studied Phenotype	Colon cancer[ ICD-11:2B90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC17A9 in colon adenocarcinoma			[ 6 ]
Location	Body (cg15606745)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.17E+00	Statistic Test	p-value:4.39E-05; Z-score:-2.18E+00
Methylation in Case	5.28E-01 (Median)	Methylation in Control	6.18E-01 (Median)
Studied Phenotype	Colon cancer[ ICD-11:2B90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC17A9 in colon adenocarcinoma			[ 6 ]
Location	Body (cg13603332)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.18E+00	Statistic Test	p-value:5.63E-05; Z-score:-2.60E+00
Methylation in Case	4.97E-01 (Median)	Methylation in Control	5.87E-01 (Median)
Studied Phenotype	Colon cancer[ ICD-11:2B90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC17A9 in colon adenocarcinoma			[ 6 ]
Location	Body (cg11034122)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.07E+00	Statistic Test	p-value:2.88E-04; Z-score:6.59E-01
Methylation in Case	7.63E-01 (Median)	Methylation in Control	7.13E-01 (Median)
Studied Phenotype	Colon cancer[ ICD-11:2B90]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC17A9 in colon adenocarcinoma			[ 6 ]
Location	Body (cg20475114)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.11E+00	Statistic Test	p-value:8.78E-04; Z-score:-1.99E+00
Methylation in Case	6.13E-01 (Median)	Methylation in Control	6.79E-01 (Median)
Studied Phenotype	Colon cancer[ ICD-11:2B90]
Experimental Material	Patient tissue samples
Colorectal cancer	9 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC17A9 in colorectal cancer			[ 7 ]
Location	TSS1500 (cg21455983)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.03E+00	Statistic Test	p-value:2.53E-06; Z-score:-1.65E+00
Methylation in Case	8.85E-01 (Median)	Methylation in Control	9.12E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC17A9 in colorectal cancer			[ 7 ]
Location	TSS1500 (cg22883889)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.16E+00	Statistic Test	p-value:9.51E-03; Z-score:-6.18E-01
Methylation in Case	3.88E-01 (Median)	Methylation in Control	4.48E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC17A9 in colorectal cancer			[ 7 ]
Location	Body (cg15677087)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.47E+00	Statistic Test	p-value:5.41E-08; Z-score:-1.98E+00
Methylation in Case	5.57E-01 (Median)	Methylation in Control	8.18E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC17A9 in colorectal cancer			[ 7 ]
Location	Body (cg13044838)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.02E+00	Statistic Test	p-value:7.74E-04; Z-score:-9.12E-01
Methylation in Case	9.06E-01 (Median)	Methylation in Control	9.24E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC17A9 in colorectal cancer			[ 7 ]
Location	Body (cg21627218)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.01E+00	Statistic Test	p-value:1.94E-03; Z-score:5.82E-01
Methylation in Case	9.59E-01 (Median)	Methylation in Control	9.53E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC17A9 in colorectal cancer			[ 7 ]
Location	Body (cg26733301)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.45E+00	Statistic Test	p-value:3.31E-02; Z-score:6.92E-01
Methylation in Case	4.19E-01 (Median)	Methylation in Control	2.89E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC17A9 in colorectal cancer			[ 7 ]
Location	Body (cg07560932)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.00E+00	Statistic Test	p-value:3.70E-02; Z-score:1.61E-01
Methylation in Case	9.32E-01 (Median)	Methylation in Control	9.29E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC17A9 in colorectal cancer			[ 7 ]
Location	3'UTR (cg13516768)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.08E+00	Statistic Test	p-value:1.25E-02; Z-score:1.03E+00
Methylation in Case	7.64E-01 (Median)	Methylation in Control	7.10E-01 (Median)
Studied Phenotype	Colorectal cancer[ ICD-11:2B91]
Experimental Material	Patient tissue samples
Hepatocellular carcinoma	17 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	TSS1500 (cg23986335)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:2.49E+00	Statistic Test	p-value:3.04E-12; Z-score:5.46E+00
Methylation in Case	2.48E-01 (Median)	Methylation in Control	9.96E-02 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	TSS1500 (cg00727912)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.36E+00	Statistic Test	p-value:1.21E-05; Z-score:-1.15E+00
Methylation in Case	1.92E-01 (Median)	Methylation in Control	2.61E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	TSS1500 (cg21455983)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:2.28E-03; Z-score:-1.54E-01
Methylation in Case	7.94E-01 (Median)	Methylation in Control	8.00E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	TSS200 (cg16552454)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.54E+00	Statistic Test	p-value:1.09E-04; Z-score:-9.34E-01
Methylation in Case	1.30E-01 (Median)	Methylation in Control	2.01E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	TSS200 (cg00199007)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.48E+00	Statistic Test	p-value:3.12E-04; Z-score:-8.44E-01
Methylation in Case	1.39E-01 (Median)	Methylation in Control	2.07E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon6	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	TSS200 (cg07173972)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.50E+00	Statistic Test	p-value:8.08E-04; Z-score:-7.44E-01
Methylation in Case	8.01E-02 (Median)	Methylation in Control	1.20E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon7	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	TSS200 (cg05534403)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.14E+00	Statistic Test	p-value:9.00E-04; Z-score:-5.10E-01
Methylation in Case	1.08E-01 (Median)	Methylation in Control	1.23E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon8	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	TSS200 (cg26329715)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.37E+00	Statistic Test	p-value:2.17E-03; Z-score:-6.32E-01
Methylation in Case	7.15E-02 (Median)	Methylation in Control	9.80E-02 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon9	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	Body (cg19969104)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.43E+00	Statistic Test	p-value:1.03E-12; Z-score:-3.38E+00
Methylation in Case	4.73E-01 (Median)	Methylation in Control	6.75E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon10	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	Body (cg15677087)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.23E+00	Statistic Test	p-value:4.23E-08; Z-score:-1.18E+00
Methylation in Case	4.40E-01 (Median)	Methylation in Control	5.40E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon11	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	Body (cg17221813)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.08E+00	Statistic Test	p-value:5.85E-06; Z-score:8.34E-01
Methylation in Case	7.87E-01 (Median)	Methylation in Control	7.27E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon12	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	Body (cg12099423)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.12E+00	Statistic Test	p-value:2.50E-05; Z-score:8.99E-01
Methylation in Case	7.14E-01 (Median)	Methylation in Control	6.40E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon13	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	Body (cg19142181)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:1.06E+00	Statistic Test	p-value:5.53E-04; Z-score:8.17E-01
Methylation in Case	8.02E-01 (Median)	Methylation in Control	7.55E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon14	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	Body (cg07560932)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:8.21E-04; Z-score:-2.66E-01
Methylation in Case	8.70E-01 (Median)	Methylation in Control	8.75E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon15	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	Body (cg24866407)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.01E+00	Statistic Test	p-value:2.19E-02; Z-score:-1.00E-01
Methylation in Case	7.99E-01 (Median)	Methylation in Control	8.05E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon16	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	3'UTR (cg12562245)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.27E+00	Statistic Test	p-value:4.43E-10; Z-score:-3.52E+00
Methylation in Case	6.10E-01 (Median)	Methylation in Control	7.76E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon17	Methylation of SLC17A9 in hepatocellular carcinoma			[ 8 ]
Location	3'UTR (cg13516768)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.02E+00	Statistic Test	p-value:2.17E-02; Z-score:-3.11E-01
Methylation in Case	8.18E-01 (Median)	Methylation in Control	8.32E-01 (Median)
Studied Phenotype	Hepatocellular carcinoma[ ICD-11:2C12.02]
Experimental Material	Patient tissue samples
Papillary thyroid cancer	5 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC17A9 in papillary thyroid cancer			[ 9 ]
Location	TSS1500 (cg00727912)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.16E+00	Statistic Test	p-value:8.26E-05; Z-score:-1.15E+00
Methylation in Case	3.69E-01 (Median)	Methylation in Control	4.29E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC17A9 in papillary thyroid cancer			[ 9 ]
Location	TSS200 (cg00199007)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.24E+00	Statistic Test	p-value:2.20E-02; Z-score:-9.27E-01
Methylation in Case	1.53E-01 (Median)	Methylation in Control	1.89E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC17A9 in papillary thyroid cancer			[ 9 ]
Location	TSS200 (cg16552454)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.19E+00	Statistic Test	p-value:3.39E-02; Z-score:-5.18E-01
Methylation in Case	1.34E-01 (Median)	Methylation in Control	1.59E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon4	Methylation of SLC17A9 in papillary thyroid cancer			[ 9 ]
Location	Body (cg15677087)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.06E+00	Statistic Test	p-value:6.21E-06; Z-score:-1.04E+00
Methylation in Case	8.34E-01 (Median)	Methylation in Control	8.82E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon5	Methylation of SLC17A9 in papillary thyroid cancer			[ 9 ]
Location	Body (cg26733301)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.18E+00	Statistic Test	p-value:1.09E-03; Z-score:-7.21E-01
Methylation in Case	9.65E-02 (Median)	Methylation in Control	1.14E-01 (Median)
Studied Phenotype	Papillary thyroid cancer[ ICD-11:2D10.1]
Experimental Material	Patient tissue samples
Panic disorder	3 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC17A9 in panic disorder			[ 10 ]
Location	TSS200 (cg00199007)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-8.56E-01	Statistic Test	p-value:7.75E-03; Z-score:-4.23E-01
Methylation in Case	-2.42E+00 (Median)	Methylation in Control	-2.07E+00 (Median)
Studied Phenotype	Panic disorder[ ICD-11:6B01]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC17A9 in panic disorder			[ 10 ]
Location	TSS200 (cg16552454)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-9.22E-01	Statistic Test	p-value:1.76E-02; Z-score:-2.60E-01
Methylation in Case	-2.55E+00 (Median)	Methylation in Control	-2.35E+00 (Median)
Studied Phenotype	Panic disorder[ ICD-11:6B01]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC17A9 in panic disorder			[ 10 ]
Location	Body (cg12099423)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:7.92E-01	Statistic Test	p-value:3.26E-02; Z-score:2.23E-01
Methylation in Case	-1.00E+00 (Median)	Methylation in Control	-1.26E+00 (Median)
Studied Phenotype	Panic disorder[ ICD-11:6B01]
Experimental Material	Patient tissue samples
Lung adenocarcinoma	3 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Methylation of SLC17A9 in lung adenocarcinoma			[ 11 ]
Location	Body (cg15677087)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.24E+00	Statistic Test	p-value:2.13E-02; Z-score:-5.21E+00
Methylation in Case	6.90E-01 (Median)	Methylation in Control	8.53E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon2	Methylation of SLC17A9 in lung adenocarcinoma			[ 11 ]
Location	Body (cg26733301)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:2.62E+00	Statistic Test	p-value:2.50E-02; Z-score:8.76E+00
Methylation in Case	2.64E-01 (Median)	Methylation in Control	1.01E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Epigenetic Phenomenon3	Methylation of SLC17A9 in lung adenocarcinoma			[ 11 ]
Location	3'UTR (cg13516768)
Epigenetic Type	Methylation	Experiment Method	Infinium HumanMethylation450 BeadChip
Methylation Fold Change	Fold Change:-1.06E+00	Statistic Test	p-value:4.34E-02; Z-score:-1.34E+00
Methylation in Case	7.79E-01 (Median)	Methylation in Control	8.23E-01 (Median)
Studied Phenotype	Lung adenocarcinoma[ ICD-11:2C25.0]
Experimental Material	Patient tissue samples
Atypical teratoid rhabdoid tumour	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypermethylation of SLC17A9 in atypical teratoid rhabdoid tumour than that in healthy individual
Studied Phenotype	Atypical teratoid rhabdoid tumour [ICD-11:2A00.1Y]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:1.03E-08; Fold-change:0.263880986; Z-score:0.982221418
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Oligodendroglial tumour	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypermethylation of SLC17A9 in oligodendroglial tumour than that in healthy individual
Studied Phenotype	Oligodendroglial tumour [ICD-11:2A00.Y1]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:6.39E-07; Fold-change:0.26472195; Z-score:8.285122349
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
RELA YAP fusion ependymoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypermethylation of SLC17A9 in rela yap fusion ependymoma than that in healthy individual
Studied Phenotype	RELA YAP fusion ependymoma [ICD-11:2A00.0Y]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:4.65E-14; Fold-change:0.234980529; Z-score:1.173571586
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Hemangioblastoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypomethylation of SLC17A9 in hemangioblastoma than that in healthy individual
Studied Phenotype	Hemangioblastoma [ICD-11:2F7C]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:0.000650138; Fold-change:-0.291900638; Z-score:-1.224212538
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Lymphoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypomethylation of SLC17A9 in lymphoma than that in healthy individual
Studied Phenotype	Lymphoma [ICD-11:2B30]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:1.25E-08; Fold-change:-0.240839604; Z-score:-1.014835171
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Medulloblastoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypomethylation of SLC17A9 in medulloblastoma than that in healthy individual
Studied Phenotype	Medulloblastoma [ICD-11:2A00.10]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:2.17E-22; Fold-change:-0.222522677; Z-score:-1.75509628
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Third ventricle chordoid glioma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Moderate hypomethylation of SLC17A9 in third ventricle chordoid glioma than that in healthy individual
Studied Phenotype	Third ventricle chordoid glioma [ICD-11:2A00.0Y]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:0.021753412; Fold-change:-0.216754726; Z-score:-0.713374711
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Brain neuroepithelial tumour	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypermethylation of SLC17A9 in brain neuroepithelial tumour than that in healthy individual
Studied Phenotype	Brain neuroepithelial tumour [ICD-11:2A00.2Y]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:8.24E-09; Fold-change:0.35935508; Z-score:1.786450057
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Diffuse midline glioma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypermethylation of SLC17A9 in diffuse midline glioma than that in healthy individual
Studied Phenotype	Diffuse midline glioma [ICD-11:2A00.0Z]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:2.17E-32; Fold-change:0.304267293; Z-score:1.57929554
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Malignant astrocytoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypermethylation of SLC17A9 in malignant astrocytoma than that in healthy individual
Studied Phenotype	Malignant astrocytoma [ICD-11:2A00.12]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:4.04E-30; Fold-change:0.362533502; Z-score:1.816657369
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Multilayered rosettes embryonal tumour	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypermethylation of SLC17A9 in multilayered rosettes embryonal tumour than that in healthy individual
Studied Phenotype	Multilayered rosettes embryonal tumour [ICD-11:2A00.1]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:4.95E-13; Fold-change:0.381499314; Z-score:1.502312287
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Oligodendroglioma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypermethylation of SLC17A9 in oligodendroglioma than that in healthy individual
Studied Phenotype	Oligodendroglioma [ICD-11:2A00.0Y]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:3.22E-19; Fold-change:0.36478069; Z-score:1.535701389
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Prostate cancer metastasis	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypermethylation of SLC17A9 in prostate cancer metastasis than that in healthy individual
Studied Phenotype	Prostate cancer metastasis [ICD-11:2.00E+06]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:9.09E-07; Fold-change:0.429926378; Z-score:9.522657867
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Uterine carcinosarcoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypermethylation of SLC17A9 in uterine carcinosarcoma than that in healthy individual
Studied Phenotype	Uterine carcinosarcoma [ICD-11:2B5F]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:0.001482859; Fold-change:0.303923323; Z-score:1.675513076
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual
Esthesioneuroblastoma	1 Epigenetic Phenomena Related to This Phenotype		Click to Show/Hide the Full List
Epigenetic Phenomenon1	Significant hypomethylation of SLC17A9 in esthesioneuroblastoma than that in healthy individual
Studied Phenotype	Esthesioneuroblastoma [ICD-11:2D50.1]
The Methylation Level of Disease Section Compare with the Healthy Individual	p-value:1.41E-07; Fold-change:-0.406146823; Z-score:-1.500463925
DT methylation level in the diseased tissue of patients DT methylation level in the normal tissue of healthy individuals
			Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue Download DT methylation data in the tissue of healthy individual

References
1	Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
2	Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
3	DNA Methylation Dynamics in Urological Tumors.
4	Genome-wide Scan for Methylation Profiles in Breast Cancer
5	A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
6	Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
7	Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
8	Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
9	Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
10	DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
11	DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.

Detail Information of Epigenetic Regulations

Visitor Map

Correspondence